Navicixizumab

navicixizumab · OncXerna Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Navicixizumab, covering 2022-08-15 to 2023-01-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors [Phase 2]